148 related articles for article (PubMed ID: 27020572)
1. Processing, fusogenicity, virion incorporation and CXCR4-binding activity of a feline immunodeficiency virus envelope glycoprotein lacking the two conserved N-glycosylation sites at the C-terminus of the V3 domain.
González SA; Affranchino JL
Arch Virol; 2016 Jul; 161(7):1761-8. PubMed ID: 27020572
[TBL] [Abstract][Full Text] [Related]
2. Palmitoylation of the feline immunodeficiency virus envelope glycoprotein and its effect on fusion activity and envelope incorporation into virions.
González SA; Paladino MG; Affranchino JL
Virology; 2012 Jun; 428(1):1-10. PubMed ID: 22503389
[TBL] [Abstract][Full Text] [Related]
3. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
Celma CC; Paladino MG; González SA; Affranchino JL
Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
[TBL] [Abstract][Full Text] [Related]
4. Replacement of the V3 domain in the surface subunit of the feline immunodeficiency virus envelope glycoprotein with the equivalent region of a T cell-tropic human immunodeficiency virus type 1 results in a chimeric surface protein that efficiently binds to CXCR4.
González SA; Falcón JI; Affranchino JL
AIDS Res Hum Retroviruses; 2014 Mar; 30(3):250-9. PubMed ID: 24148007
[TBL] [Abstract][Full Text] [Related]
5. Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein.
Sundstrom M; White RL; de Parseval A; Sastry KJ; Morris G; Grant CK; Elder JH
J Virol; 2008 Sep; 82(18):9134-42. PubMed ID: 18596086
[TBL] [Abstract][Full Text] [Related]
6. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
Affranchino JL; González SA
Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
[TBL] [Abstract][Full Text] [Related]
7. Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virus.
Hu QY; Fink E; Grant CK; Elder JH
PLoS One; 2014; 9(12):e115252. PubMed ID: 25521480
[TBL] [Abstract][Full Text] [Related]
8. Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.
Hu QY; Fink E; Happer M; Elder JH
J Virol; 2011 Jul; 85(14):7108-17. PubMed ID: 21543468
[TBL] [Abstract][Full Text] [Related]
9. A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.
Willett BJ; McMonagle EL; Logan N; Samman A; Hosie MJ
Retrovirology; 2008 Aug; 5():77. PubMed ID: 18721458
[TBL] [Abstract][Full Text] [Related]
10. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.
de Parseval A; Elder JH
J Virol; 2001 May; 75(10):4528-39. PubMed ID: 11312323
[TBL] [Abstract][Full Text] [Related]
11. Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope.
de Parseval A; Grant CK; Sastry KJ; Elder JH
J Virol; 2006 Mar; 80(6):3088-91. PubMed ID: 16501119
[TBL] [Abstract][Full Text] [Related]
12. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
Morrison JH; Guevara RB; Marcano AC; Saenz DT; Fadel HJ; Rogstad DK; Poeschla EM
J Virol; 2014 Mar; 88(6):3255-72. PubMed ID: 24390322
[TBL] [Abstract][Full Text] [Related]
13. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
14. Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein.
Celestino M; Calistri A; Del Vecchio C; Salata C; Chiuppesi F; Pistello M; Borsetti A; Palù G; Parolin C
J Virol; 2012 Jun; 86(12):6688-700. PubMed ID: 22514338
[TBL] [Abstract][Full Text] [Related]
15. Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.
Hu QY; Fink E; Hong Y; Wang C; Grant CK; Elder JH
PLoS One; 2010 May; 5(5):e10689. PubMed ID: 20502526
[TBL] [Abstract][Full Text] [Related]
16. Feline immunodeficiency virus envelope glycoprotein mediates apoptosis in activated PBMC by a mechanism dependent on gp41 function.
Garg H; Joshi A; Tompkins WA
Virology; 2004 Dec; 330(2):424-36. PubMed ID: 15567436
[TBL] [Abstract][Full Text] [Related]
17. Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.
Johnston JB; Power C
J Virol; 2002 Apr; 76(8):3626-36. PubMed ID: 11907202
[TBL] [Abstract][Full Text] [Related]
18. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.
Willett BJ; Picard L; Hosie MJ; Turner JD; Adema K; Clapham PR
J Virol; 1997 Sep; 71(9):6407-15. PubMed ID: 9261358
[TBL] [Abstract][Full Text] [Related]
19. Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus.
de Parseval A; Chatterji U; Morris G; Sun P; Olson AJ; Elder JH
Nat Struct Mol Biol; 2005 Jan; 12(1):60-6. PubMed ID: 15592478
[TBL] [Abstract][Full Text] [Related]
20. Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor.
Meister S; Otto C; Papkalla A; Krumbiegel M; Pöhlmann S; Kirchhoff F
Virology; 2001 Jun; 284(2):287-96. PubMed ID: 11384227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
